The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus S. AndrikopoulosJ. Proietto Originals Pages: 1389 - 1396
Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass E. F. LampeterM. TubesH. Kolb Originals Pages: 1397 - 1404
Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats R. N. WangG. KlöppelL. Bouwens Originals Pages: 1405 - 1411
Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM A. MaranJ. LomasS. A. Amiel Originals Pages: 1412 - 1418
Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control? L. PattiL. Di MarinoA. A. Rivellese Originals Pages: 1419 - 1424
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid D. ZieglerM. HanefeldThe ALADIN Study Group Originals Pages: 1425 - 1433
Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients K. HirataK. SakuK. Arakawa Originals Pages: 1434 - 1442
Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria K. StrojekW. GrzeszczakE. Ritz Originals Pages: 1443 - 1448
Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM C. GiordanoR. De MariaA. Galluzzo Originals Pages: 1449 - 1454
Alterations of glomerular basement membrane charge and structure in diabetic nephropathy N. P. GoodeM. ShiresA. M. Davison Originals Pages: 1455 - 1465
Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity M. LehtoX. HuangL. Groop Originals Pages: 1466 - 1474
Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta A. KeeganH. WalbankN. E. Cameron Rapid Communications Pages: 1475 - 1478
Linkage studies in NIDDM with markers near the sulphonylurea receptor gene B. StirlingN. J. CoxP. Concannon Rapid Communications Pages: 1479 - 1481
Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? H. M. Ledermann Letter to the Editors Pages: 1482 - 1482
Testing parents of NIDDM patients J. C. AlcoladoB. D. Mitchell Letter to the Editors Pages: 1482 - 1484
Is oxidative stress the missing link between insulin resistance and atherosclerosis? A. Ceriello Letter to the Editors Pages: 1484 - 1485
Could coenzyme Q10 and l-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? B. Vialettes Letter to the Editors Pages: 1485 - 1486
Could differences in body mass index and/or insulin sensitivity explain the association between parental diabetic nephropathy and risk of diabetes in offspring? R. J. SigalD. R. McCance Letter to the Editors Pages: 1486 - 1487
Are MELAS and diabetes mellitus caused solely by the same mutation at np 3243 of the mitochondrial gene? M. OdawaraM. Hashiramoto Letter to the Editors Pages: 1488 - 1490
Exclusion of adenosine deaminase gene locus on chromosome 20q12–13.1 in familial NIDDM in Taiwanese patients B. J. Lin Letter to the Editors Pages: 1490 - 1491
Is human insulin without effect in the diabetic rat? O. TorffvitT. Soulis-Liparota Letter to the Editors Pages: 1492 - 1493
Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM H. Ikegami Letter to the Editors Pages: 1493 - 1495
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene Letter to the Editors Pages: 1495 - 1496
